Directed new share issue in CELLINK AB (SE) — SEK 377 million

Carnegie acted as sole bookrunner in the directed new share issue of 3,890,000 new shares at a subscription price of SEK 97 per share. CELLINK is a niche life-science company developing and delivering solutions for cell culturing. January 2020.